Arbitration Board Setting Reimbursement Amounts For Pharmaceutical Innovations In Germany When Price Negations Between Payors And Manufacturers Fail- An Empirical Analysis Of 5 Years' Experience
Abstract
Authors
S Ludwig C Dintsios